Data Mining of the Public Version of the FDA Adverse Event Reporting System
Top Cited Papers
Open Access
- 1 January 2013
- journal article
- review article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 10 (7), 796-803
- https://doi.org/10.7150/ijms.6048
Abstract
The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS, formerly AERS) is a database that contains information on adverse event and medication error reports submitted to the FDA. Besides those from manufacturers, reports can be submitted from health care professionals and the public. The original system was started in 1969, but since the last major revision in 1997, reporting has markedly increased. Data mining algorithms have been developed for the quantitative detection of signals from such a large database, where a signal means a statistical association between a drug and an adverse event or a drug-associated adverse event, including the proportional reporting ratio (PRR), the reporting odds ratio (ROR), the information component (IC), and the empirical Bayes geometric mean (EBGM). A survey of our previous reports suggested that the ROR provided the highest number of signals, and the EBGM the lowest. Additionally, an analysis of warfarin-, aspirin- and clopidogrel-associated adverse events suggested that all EBGM-based signals were included in the PRR-based signals, and also in the IC- or ROR-based ones, and that the PRR- and IC-based signals were in the ROR-based ones. In this article, the latest information on this area is summarized for future pharmacoepidemiological studies and/or pharmacovigilance analyses.Keywords
This publication has 91 references indexed in Scilit:
- Cetuximab infusion reactions: French pharmacovigilance database analysisJournal of Oncology Pharmacy Practice, 2012
- Drug FeverDrug Safety, 2012
- A pre-marketing ALT signal predicts post-marketing liver safetyRegulatory Toxicology and Pharmacology, 2012
- Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case ApproachPLOS ONE, 2012
- Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)Pharmacoepidemiology and Drug Safety, 2012
- Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance databaseEuropean Journal of Clinical Pharmacology, 2012
- Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting SystemBiological & Pharmaceutical Bulletin, 2012
- Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERSInternational Journal of Medical Sciences, 2012
- Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting SystemInternational Journal of Medical Sciences, 2012
- The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance databaseActa Diabetologica, 2011